Cystic Neutrophilic Granulomatous Mastitis Regression with the Tumor Necrosis Factor-α Inhibitor, Adalimumab
Idiopathic granulomatous mastitis (IGM) is a rare, benign, inflammatory breast disease that primarily affects parous women within a period of five years post-partum. Cystic neutrophilic granulomatous mastitis (CNGM) is clinically identical to IGM, but histopathology demonstrates distinct central lip...
Main Authors: | Le Wen Chiu, Karen Goodwin, Poonam Vohra, Erin Amerson |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2022-01-01
|
Series: | European Journal of Breast Health |
Subjects: | |
Online Access: |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/cystic-neutrophilic-granulomatous-mastitis-regress/49527
|
Similar Items
-
Granulomatous Neutrophilic Cystic Mastitis, Case Report
by: Katherine Luisa Contreras Gala, et al.
Published: (2021-01-01) -
Outcomes from treatment of Granulomatous lobular mastitis
by: Yuliya B. Olimpiadi, et al.
Published: (2021-12-01) -
Role of Bacteriological Agents in Idiopathic Granulomatous Mastitis: Real or Not?
by: Taner Kıvılcım, et al.
Published: (2019-01-01) -
Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition)
by: Qian-Qian Yuan, et al.
Published: (2022-04-01) -
Granulomatous mastitis: An underdiagnosed inflammatory disease afflicting minority women
by: Daniel R. Bacon, BS, et al.
Published: (2021-12-01)